Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
08 Ottobre 2024 - 2:30PM
Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the
“Company”), a medical device company focused on advancing
innovative technologies to revolutionize how diseases involving the
nervous system are diagnosed and treated, today announced that Brad
Hauser, CEO of Autonomix, will participate in a fireside chat at
the 2024 Healthcare Virtual Summit, presented by Maxim Group LLC on
October 15, 2024 at 2:30 PM ET.
Maxim Senior Analysts will host a wide range of
biotechnology, diagnostic, medical device, and healthcare
information technology companies in a series of presentations and
interactive discussions with CEOs and key management. Maxim also
plans to host several topical industry panels that promise to be
timely and engaging. To attend, just sign up to become an M-Vest
member and stay tuned for more updates
Click Here to Reserve Your Seat.
About Autonomix Medical,
Inc.
Autonomix is a medical device company focused on
advancing innovative technologies to revolutionize how diseases
involving the nervous system are diagnosed and treated. The
Company’s first-in-class platform system technology includes a
catheter-based microchip sensing array that may have the ability to
detect and differentiate neural signals with approximately 3,000
times greater sensitivity than currently available technologies. We
believe this will enable, for the first time ever, transvascular
diagnosis and treatment of diseases involving the peripheral
nervous system virtually anywhere in the body.
We are initially developing this technology for
the treatment of pain, with initial trials focused on pancreatic
cancer, a condition that causes debilitating pain and is without a
reliable solution. Our technology constitutes a platform to address
dozens of indications, including cardiology, hypertension and
chronic pain management, across a wide disease spectrum. Our
technology is investigational and has not yet been cleared for
marketing in the United States.
For more information, visit autonomix.com and
connect with the Company on X, LinkedIn, Instagram and
Facebook.
Investor and Media ContactJTC Team, LLCJenene
Thomas908.824.0775autonomix@jtcir.com
Grafico Azioni Autonomix Medical (NASDAQ:AMIX)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Autonomix Medical (NASDAQ:AMIX)
Storico
Da Dic 2023 a Dic 2024